Concepts (424)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malaria, Falciparum | 37 | 2024 | 1077 | 4.740 |
Why?
|
Plasmodium falciparum | 42 | 2024 | 1741 | 4.710 |
Why?
|
Malaria | 24 | 2023 | 1249 | 3.560 |
Why?
|
Travel | 22 | 2021 | 805 | 3.060 |
Why?
|
Disease Outbreaks | 14 | 2021 | 1761 | 2.860 |
Why?
|
Protozoan Proteins | 16 | 2024 | 843 | 2.150 |
Why?
|
Plasmodium | 8 | 2021 | 248 | 1.990 |
Why?
|
Population Dynamics | 10 | 2021 | 314 | 1.790 |
Why?
|
Models, Theoretical | 21 | 2024 | 3573 | 1.680 |
Why?
|
Communicable Diseases | 11 | 2024 | 874 | 1.620 |
Why?
|
Neisseria meningitidis | 6 | 2014 | 111 | 1.550 |
Why?
|
Epidemics | 7 | 2022 | 517 | 1.530 |
Why?
|
Quarantine | 3 | 2021 | 186 | 1.330 |
Why?
|
Dengue | 4 | 2022 | 258 | 1.280 |
Why?
|
Models, Biological | 20 | 2022 | 9495 | 1.270 |
Why?
|
Parasites | 6 | 2023 | 160 | 1.250 |
Why?
|
Cholera | 3 | 2020 | 754 | 1.230 |
Why?
|
Population Surveillance | 7 | 2021 | 2596 | 1.130 |
Why?
|
Cyclonic Storms | 2 | 2019 | 121 | 1.120 |
Why?
|
Antigenic Variation | 7 | 2019 | 117 | 1.070 |
Why?
|
Forecasting | 7 | 2021 | 2945 | 1.060 |
Why?
|
Host-Parasite Interactions | 8 | 2021 | 303 | 1.060 |
Why?
|
Culicidae | 8 | 2015 | 111 | 1.040 |
Why?
|
Genome, Protozoan | 5 | 2024 | 153 | 1.020 |
Why?
|
Seasons | 5 | 2020 | 1524 | 0.990 |
Why?
|
Plasmodium vivax | 5 | 2024 | 203 | 0.970 |
Why?
|
Evolution, Molecular | 6 | 2015 | 1896 | 0.910 |
Why?
|
Coronavirus Infections | 9 | 2020 | 3115 | 0.900 |
Why?
|
Antigens, Protozoan | 9 | 2014 | 315 | 0.890 |
Why?
|
Bangladesh | 8 | 2021 | 742 | 0.860 |
Why?
|
Mosquito Control | 5 | 2019 | 110 | 0.860 |
Why?
|
Pneumonia, Viral | 8 | 2020 | 3238 | 0.850 |
Why?
|
Transportation | 2 | 2021 | 217 | 0.810 |
Why?
|
Pandemics | 14 | 2021 | 8748 | 0.770 |
Why?
|
Communicable Disease Control | 7 | 2021 | 857 | 0.730 |
Why?
|
Social Conditions | 1 | 2021 | 121 | 0.720 |
Why?
|
Chagas Disease | 1 | 2022 | 166 | 0.720 |
Why?
|
Trypanosoma cruzi | 1 | 2022 | 204 | 0.710 |
Why?
|
Antimalarials | 9 | 2024 | 909 | 0.710 |
Why?
|
Genetics, Population | 7 | 2021 | 944 | 0.700 |
Why?
|
Hemorrhagic Fever, Ebola | 3 | 2020 | 424 | 0.680 |
Why?
|
Topography, Medical | 1 | 2019 | 37 | 0.650 |
Why?
|
Insect Vectors | 8 | 2016 | 136 | 0.650 |
Why?
|
Rotavirus Infections | 1 | 2020 | 85 | 0.630 |
Why?
|
Selection, Genetic | 5 | 2016 | 877 | 0.620 |
Why?
|
Contact Tracing | 2 | 2021 | 275 | 0.620 |
Why?
|
Thailand | 6 | 2021 | 288 | 0.610 |
Why?
|
Information Dissemination | 3 | 2021 | 1143 | 0.610 |
Why?
|
Disaster Planning | 2 | 2021 | 560 | 0.600 |
Why?
|
Antigens | 3 | 2015 | 1442 | 0.590 |
Why?
|
Immunity, Herd | 1 | 2018 | 48 | 0.580 |
Why?
|
Models, Statistical | 10 | 2022 | 5107 | 0.580 |
Why?
|
Gold | 1 | 2021 | 488 | 0.580 |
Why?
|
Bacterial Outer Membrane Proteins | 4 | 2014 | 404 | 0.580 |
Why?
|
Kenya | 9 | 2024 | 757 | 0.570 |
Why?
|
Models, Genetic | 5 | 2020 | 3447 | 0.560 |
Why?
|
Malaria, Vivax | 4 | 2024 | 168 | 0.540 |
Why?
|
Drug Resistance | 7 | 2024 | 1599 | 0.530 |
Why?
|
Disease Transmission, Infectious | 2 | 2021 | 560 | 0.530 |
Why?
|
Gorilla gorilla | 1 | 2015 | 29 | 0.520 |
Why?
|
Demography | 4 | 2019 | 1641 | 0.500 |
Why?
|
Communicable Diseases, Emerging | 1 | 2017 | 149 | 0.490 |
Why?
|
Rubella | 1 | 2015 | 55 | 0.490 |
Why?
|
Pan troglodytes | 1 | 2015 | 224 | 0.490 |
Why?
|
Erythrocytes | 4 | 2021 | 2418 | 0.490 |
Why?
|
Computer Simulation | 7 | 2023 | 6283 | 0.480 |
Why?
|
Cholera Vaccines | 1 | 2018 | 264 | 0.480 |
Why?
|
Phylogeny | 4 | 2021 | 2843 | 0.470 |
Why?
|
Genetic Variation | 11 | 2024 | 6611 | 0.470 |
Why?
|
Humans | 125 | 2024 | 768166 | 0.460 |
Why?
|
Guyana | 3 | 2024 | 17 | 0.450 |
Why?
|
Movement | 1 | 2021 | 1490 | 0.450 |
Why?
|
Global Warming | 1 | 2014 | 79 | 0.440 |
Why?
|
Behavior | 2 | 2020 | 542 | 0.420 |
Why?
|
Stochastic Processes | 5 | 2015 | 360 | 0.410 |
Why?
|
Anopheles | 4 | 2020 | 193 | 0.400 |
Why?
|
Molecular Epidemiology | 4 | 2024 | 473 | 0.400 |
Why?
|
alpha-Thalassemia | 1 | 2012 | 53 | 0.390 |
Why?
|
Disasters | 1 | 2018 | 521 | 0.390 |
Why?
|
Cities | 4 | 2022 | 543 | 0.380 |
Why?
|
DNA, Protozoan | 5 | 2018 | 227 | 0.380 |
Why?
|
Selection Bias | 1 | 2013 | 360 | 0.370 |
Why?
|
Health Services Accessibility | 3 | 2019 | 5520 | 0.360 |
Why?
|
Geographic Information Systems | 4 | 2021 | 283 | 0.360 |
Why?
|
Vaccination | 5 | 2024 | 3437 | 0.350 |
Why?
|
Models, Psychological | 1 | 2014 | 825 | 0.350 |
Why?
|
Weather | 2 | 2022 | 234 | 0.350 |
Why?
|
Antigens, Bacterial | 3 | 2011 | 1150 | 0.340 |
Why?
|
Host-Pathogen Interactions | 9 | 2021 | 1469 | 0.340 |
Why?
|
Meningitis, Meningococcal | 1 | 2010 | 43 | 0.340 |
Why?
|
beta-Thalassemia | 1 | 2012 | 234 | 0.340 |
Why?
|
Data Collection | 4 | 2021 | 3327 | 0.330 |
Why?
|
Genetic Heterogeneity | 1 | 2013 | 736 | 0.330 |
Why?
|
Ownership | 1 | 2012 | 338 | 0.330 |
Why?
|
Employment | 1 | 2015 | 1110 | 0.310 |
Why?
|
Biological Evolution | 3 | 2016 | 1076 | 0.310 |
Why?
|
Gene Flow | 3 | 2021 | 79 | 0.310 |
Why?
|
Uncertainty | 4 | 2021 | 769 | 0.310 |
Why?
|
Virulence Factors | 1 | 2012 | 502 | 0.310 |
Why?
|
Primaquine | 2 | 2019 | 28 | 0.310 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2015 | 843 | 0.300 |
Why?
|
Artemisinins | 4 | 2024 | 217 | 0.290 |
Why?
|
Mortality | 2 | 2021 | 2911 | 0.290 |
Why?
|
Genomics | 6 | 2024 | 5926 | 0.290 |
Why?
|
Gene Frequency | 4 | 2022 | 3623 | 0.280 |
Why?
|
Prenatal Care | 1 | 2015 | 1162 | 0.280 |
Why?
|
Geography | 5 | 2021 | 652 | 0.270 |
Why?
|
Sequence Analysis, DNA | 4 | 2015 | 4786 | 0.270 |
Why?
|
Animals | 42 | 2023 | 169246 | 0.270 |
Why?
|
Carrier State | 1 | 2010 | 529 | 0.260 |
Why?
|
Mass Vaccination | 2 | 2018 | 111 | 0.250 |
Why?
|
Models, Immunological | 1 | 2008 | 518 | 0.250 |
Why?
|
Data Interpretation, Statistical | 1 | 2015 | 2709 | 0.250 |
Why?
|
Computational Biology | 2 | 2013 | 3568 | 0.230 |
Why?
|
Incidence | 11 | 2022 | 21538 | 0.230 |
Why?
|
Pakistan | 4 | 2018 | 299 | 0.220 |
Why?
|
Adaptation, Psychological | 1 | 2014 | 2663 | 0.220 |
Why?
|
Parasitemia | 2 | 2022 | 166 | 0.210 |
Why?
|
Ecosystem | 1 | 2007 | 494 | 0.210 |
Why?
|
Motor Activity | 1 | 2013 | 2711 | 0.210 |
Why?
|
Sierra Leone | 2 | 2020 | 171 | 0.200 |
Why?
|
Immunity, Innate | 1 | 2014 | 3080 | 0.200 |
Why?
|
Developing Countries | 1 | 2015 | 2910 | 0.200 |
Why?
|
Public Health | 5 | 2021 | 2679 | 0.190 |
Why?
|
Epidemiologic Methods | 2 | 2020 | 1328 | 0.190 |
Why?
|
Health Policy | 3 | 2024 | 2698 | 0.190 |
Why?
|
Reproduction, Asexual | 1 | 2020 | 13 | 0.180 |
Why?
|
Mining | 1 | 2021 | 93 | 0.180 |
Why?
|
Urban Population | 5 | 2021 | 2046 | 0.180 |
Why?
|
Asia, Southeastern | 2 | 2021 | 115 | 0.180 |
Why?
|
Genome, Viral | 2 | 2021 | 674 | 0.180 |
Why?
|
Molecular Sequence Data | 8 | 2015 | 17622 | 0.180 |
Why?
|
Climate | 1 | 2021 | 146 | 0.180 |
Why?
|
Voluntary Programs | 1 | 2020 | 48 | 0.180 |
Why?
|
Chikungunya virus | 1 | 2021 | 56 | 0.180 |
Why?
|
Policy | 2 | 2021 | 513 | 0.170 |
Why?
|
Child, Preschool | 10 | 2024 | 42669 | 0.170 |
Why?
|
Antibodies, Protozoan | 3 | 2020 | 251 | 0.170 |
Why?
|
Erythrocyte Count | 1 | 2020 | 157 | 0.170 |
Why?
|
Prevalence | 9 | 2022 | 15869 | 0.170 |
Why?
|
Colombia | 1 | 2020 | 287 | 0.170 |
Why?
|
Mozambique | 1 | 2019 | 55 | 0.170 |
Why?
|
Recombination, Genetic | 3 | 2010 | 1525 | 0.170 |
Why?
|
Czech Republic | 2 | 2010 | 75 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2020 | 16045 | 0.160 |
Why?
|
Emigration and Immigration | 2 | 2013 | 406 | 0.160 |
Why?
|
Seroepidemiologic Studies | 3 | 2023 | 404 | 0.160 |
Why?
|
Dengue Virus | 1 | 2021 | 204 | 0.160 |
Why?
|
Sentinel Surveillance | 1 | 2021 | 292 | 0.160 |
Why?
|
Homes for the Aged | 1 | 2021 | 273 | 0.160 |
Why?
|
Locomotion | 1 | 2021 | 388 | 0.160 |
Why?
|
Rotavirus | 1 | 2020 | 110 | 0.160 |
Why?
|
Data Mining | 2 | 2021 | 563 | 0.150 |
Why?
|
Dust | 1 | 2021 | 488 | 0.150 |
Why?
|
Measles Vaccine | 1 | 2018 | 79 | 0.150 |
Why?
|
Erythrocytes, Abnormal | 1 | 2018 | 121 | 0.150 |
Why?
|
Socioeconomic Factors | 3 | 2021 | 7852 | 0.150 |
Why?
|
Mycobacterium tuberculosis | 2 | 2022 | 1930 | 0.150 |
Why?
|
Privacy | 1 | 2020 | 233 | 0.150 |
Why?
|
Infant | 9 | 2021 | 36535 | 0.150 |
Why?
|
Sickle Cell Trait | 1 | 2018 | 86 | 0.150 |
Why?
|
Population Density | 2 | 2015 | 193 | 0.140 |
Why?
|
Public Health Practice | 1 | 2020 | 221 | 0.140 |
Why?
|
HIV | 2 | 2015 | 1597 | 0.140 |
Why?
|
Culture | 1 | 2021 | 622 | 0.140 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2021 | 497 | 0.140 |
Why?
|
Orthomyxoviridae | 1 | 2018 | 148 | 0.140 |
Why?
|
Juvenile Hormones | 1 | 2016 | 15 | 0.140 |
Why?
|
Africa South of the Sahara | 2 | 2021 | 752 | 0.140 |
Why?
|
Policy Making | 1 | 2021 | 546 | 0.140 |
Why?
|
Smallpox | 1 | 2017 | 43 | 0.140 |
Why?
|
Puerto Rico | 1 | 2018 | 380 | 0.140 |
Why?
|
Malaria Vaccines | 2 | 2009 | 165 | 0.140 |
Why?
|
Child | 13 | 2024 | 80917 | 0.140 |
Why?
|
Markov Chains | 1 | 2020 | 979 | 0.140 |
Why?
|
Genotype | 5 | 2020 | 13045 | 0.140 |
Why?
|
Poliovirus | 1 | 2017 | 106 | 0.140 |
Why?
|
Oviposition | 1 | 2016 | 22 | 0.130 |
Why?
|
Rubella Vaccine | 1 | 2016 | 23 | 0.130 |
Why?
|
Poliomyelitis | 1 | 2017 | 91 | 0.130 |
Why?
|
Hepatitis A | 1 | 2017 | 126 | 0.130 |
Why?
|
Genes, Protozoan | 4 | 2014 | 170 | 0.130 |
Why?
|
Immune Evasion | 1 | 2020 | 375 | 0.130 |
Why?
|
Influenza, Human | 2 | 2018 | 1541 | 0.130 |
Why?
|
Rubella Syndrome, Congenital | 1 | 2016 | 12 | 0.130 |
Why?
|
Wolbachia | 1 | 2016 | 21 | 0.130 |
Why?
|
Adhesins, Bacterial | 2 | 2014 | 118 | 0.130 |
Why?
|
Measles | 1 | 2018 | 180 | 0.130 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2017 | 136 | 0.130 |
Why?
|
Synteny | 1 | 2015 | 77 | 0.130 |
Why?
|
Risk Management | 1 | 2019 | 558 | 0.130 |
Why?
|
Internet | 2 | 2022 | 3110 | 0.130 |
Why?
|
Virulence | 4 | 2015 | 1297 | 0.120 |
Why?
|
Immunization, Secondary | 1 | 2018 | 373 | 0.120 |
Why?
|
Family Characteristics | 1 | 2020 | 1003 | 0.120 |
Why?
|
Adaptation, Biological | 1 | 2016 | 147 | 0.120 |
Why?
|
Hydrazines | 1 | 2016 | 223 | 0.120 |
Why?
|
Haplotypes | 3 | 2017 | 2722 | 0.120 |
Why?
|
Amino Acid Sequence | 5 | 2014 | 13421 | 0.120 |
Why?
|
Adolescent | 13 | 2024 | 89169 | 0.120 |
Why?
|
Africa | 3 | 2024 | 725 | 0.120 |
Why?
|
Insecticides | 1 | 2016 | 200 | 0.120 |
Why?
|
Rural Population | 3 | 2021 | 2325 | 0.120 |
Why?
|
Monte Carlo Method | 1 | 2020 | 1259 | 0.120 |
Why?
|
Alleles | 3 | 2011 | 6894 | 0.120 |
Why?
|
Immunity, Humoral | 1 | 2019 | 610 | 0.120 |
Why?
|
Time Factors | 6 | 2019 | 40218 | 0.120 |
Why?
|
Poverty | 3 | 2021 | 2720 | 0.110 |
Why?
|
Polymorphism, Genetic | 2 | 2019 | 4249 | 0.110 |
Why?
|
Parasitic Diseases | 1 | 2014 | 76 | 0.110 |
Why?
|
Nursing Homes | 1 | 2021 | 1084 | 0.110 |
Why?
|
Plasmodium knowlesi | 1 | 2013 | 23 | 0.100 |
Why?
|
International Cooperation | 1 | 2019 | 1436 | 0.100 |
Why?
|
Mediterranean Islands | 1 | 2012 | 2 | 0.100 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1561 | 0.100 |
Why?
|
Young Adult | 10 | 2024 | 60066 | 0.100 |
Why?
|
Mediterranean Region | 1 | 2012 | 47 | 0.100 |
Why?
|
National Health Programs | 1 | 2016 | 442 | 0.100 |
Why?
|
Public Policy | 1 | 2016 | 552 | 0.100 |
Why?
|
Histocompatibility Antigens | 1 | 2013 | 479 | 0.100 |
Why?
|
Insecticide-Treated Bednets | 3 | 2019 | 70 | 0.100 |
Why?
|
Age Distribution | 1 | 2018 | 2873 | 0.100 |
Why?
|
Algorithms | 6 | 2021 | 14164 | 0.100 |
Why?
|
Adult | 16 | 2024 | 223646 | 0.100 |
Why?
|
Social Class | 1 | 2021 | 2008 | 0.100 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14783 | 0.100 |
Why?
|
Zoonoses | 1 | 2013 | 180 | 0.100 |
Why?
|
Censuses | 1 | 2013 | 198 | 0.100 |
Why?
|
Greece | 1 | 2012 | 340 | 0.100 |
Why?
|
Sequence Alignment | 2 | 2013 | 2179 | 0.090 |
Why?
|
Female | 22 | 2024 | 397192 | 0.090 |
Why?
|
Pneumococcal Vaccines | 1 | 2015 | 414 | 0.090 |
Why?
|
Pedigree | 1 | 2019 | 4539 | 0.090 |
Why?
|
Health Status Disparities | 2 | 2020 | 1885 | 0.090 |
Why?
|
Endemic Diseases | 1 | 2012 | 191 | 0.090 |
Why?
|
Cause of Death | 2 | 2020 | 3721 | 0.090 |
Why?
|
DNA Replication | 1 | 2018 | 1427 | 0.090 |
Why?
|
Bayes Theorem | 4 | 2021 | 2359 | 0.090 |
Why?
|
Climate Change | 1 | 2017 | 509 | 0.090 |
Why?
|
Risk Assessment | 4 | 2021 | 24315 | 0.090 |
Why?
|
Pneumococcal Infections | 1 | 2015 | 529 | 0.090 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4568 | 0.090 |
Why?
|
Residence Characteristics | 1 | 2020 | 2118 | 0.090 |
Why?
|
Uganda | 3 | 2024 | 1361 | 0.090 |
Why?
|
Italy | 1 | 2012 | 856 | 0.090 |
Why?
|
Cross Reactions | 2 | 2011 | 828 | 0.090 |
Why?
|
Epistasis, Genetic | 1 | 2012 | 353 | 0.090 |
Why?
|
Cluster Analysis | 4 | 2020 | 2732 | 0.080 |
Why?
|
Porins | 1 | 2010 | 78 | 0.080 |
Why?
|
Histone Deacetylases | 1 | 2014 | 717 | 0.080 |
Why?
|
Streptococcus pneumoniae | 1 | 2015 | 764 | 0.080 |
Why?
|
Age Factors | 3 | 2021 | 18412 | 0.080 |
Why?
|
Immune System | 1 | 2015 | 799 | 0.080 |
Why?
|
Transients and Migrants | 1 | 2012 | 170 | 0.080 |
Why?
|
Self Report | 1 | 2021 | 3773 | 0.080 |
Why?
|
Tuberculosis | 1 | 2022 | 2029 | 0.080 |
Why?
|
Sirtuins | 1 | 2012 | 322 | 0.080 |
Why?
|
Male | 16 | 2024 | 364719 | 0.080 |
Why?
|
HIV Infections | 1 | 2015 | 17569 | 0.080 |
Why?
|
HLA Antigens | 1 | 2013 | 1334 | 0.070 |
Why?
|
Wasps | 1 | 2007 | 15 | 0.070 |
Why?
|
Parthenogenesis | 1 | 2007 | 30 | 0.070 |
Why?
|
Immunity, Active | 1 | 2008 | 58 | 0.070 |
Why?
|
Survival Analysis | 1 | 2020 | 10101 | 0.070 |
Why?
|
Collagen | 3 | 1991 | 2643 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2015 | 2434 | 0.070 |
Why?
|
Anti-Infective Agents | 1 | 2015 | 983 | 0.070 |
Why?
|
Madagascar | 2 | 2018 | 111 | 0.070 |
Why?
|
United States | 5 | 2021 | 73039 | 0.070 |
Why?
|
Expressed Sequence Tags | 1 | 2007 | 251 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8054 | 0.070 |
Why?
|
Middle Aged | 11 | 2024 | 223492 | 0.070 |
Why?
|
Oxygen | 1 | 2018 | 4270 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20227 | 0.070 |
Why?
|
Epigenomics | 1 | 2012 | 960 | 0.070 |
Why?
|
Vietnam | 2 | 2018 | 415 | 0.060 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 1312 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 6211 | 0.060 |
Why?
|
Immunity | 1 | 2011 | 1003 | 0.060 |
Why?
|
Life Cycle Stages | 2 | 2016 | 161 | 0.060 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 3772 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26379 | 0.060 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2021 | 1049 | 0.060 |
Why?
|
Educational Status | 1 | 2012 | 2515 | 0.060 |
Why?
|
China | 2 | 2021 | 2395 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8375 | 0.060 |
Why?
|
India | 2 | 2021 | 2334 | 0.060 |
Why?
|
Risk Factors | 6 | 2021 | 74944 | 0.060 |
Why?
|
Decision Making | 3 | 2024 | 3953 | 0.060 |
Why?
|
Gene Expression | 2 | 2013 | 7598 | 0.050 |
Why?
|
Adaptive Immunity | 2 | 2021 | 733 | 0.050 |
Why?
|
Base Sequence | 2 | 2012 | 12421 | 0.050 |
Why?
|
South America | 1 | 2022 | 180 | 0.050 |
Why?
|
Infection Control | 2 | 2020 | 985 | 0.050 |
Why?
|
Antibodies | 1 | 1990 | 2421 | 0.050 |
Why?
|
Eukaryota | 1 | 2022 | 101 | 0.050 |
Why?
|
Logistic Models | 2 | 2017 | 13290 | 0.050 |
Why?
|
Basic Reproduction Number | 1 | 2021 | 38 | 0.050 |
Why?
|
Democratic Republic of the Congo | 1 | 2021 | 87 | 0.050 |
Why?
|
Rwanda | 1 | 2024 | 671 | 0.050 |
Why?
|
Chloroquine | 1 | 2022 | 276 | 0.050 |
Why?
|
Phylogeography | 1 | 2021 | 72 | 0.050 |
Why?
|
Infectious Disease Incubation Period | 1 | 2020 | 16 | 0.050 |
Why?
|
Mali | 1 | 2021 | 51 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2008 | 6082 | 0.050 |
Why?
|
Africa, Northern | 1 | 2021 | 86 | 0.050 |
Why?
|
Infant, Newborn | 3 | 2021 | 26422 | 0.040 |
Why?
|
Aged | 7 | 2021 | 171504 | 0.040 |
Why?
|
Chile | 1 | 2021 | 258 | 0.040 |
Why?
|
Air Microbiology | 1 | 2021 | 95 | 0.040 |
Why?
|
Cambodia | 1 | 2020 | 185 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2018 | 59629 | 0.040 |
Why?
|
Myanmar | 1 | 2019 | 43 | 0.040 |
Why?
|
Aedes | 1 | 2021 | 101 | 0.040 |
Why?
|
Aircraft | 1 | 2021 | 135 | 0.040 |
Why?
|
Taiwan | 1 | 2021 | 521 | 0.040 |
Why?
|
Atovaquone | 1 | 2019 | 56 | 0.040 |
Why?
|
Cytochromes b | 1 | 2019 | 35 | 0.040 |
Why?
|
Tropical Climate | 1 | 2018 | 35 | 0.040 |
Why?
|
Urban Health | 1 | 2021 | 535 | 0.040 |
Why?
|
Namibia | 1 | 2017 | 28 | 0.040 |
Why?
|
Antisickling Agents | 1 | 2018 | 72 | 0.040 |
Why?
|
Software | 1 | 2012 | 4478 | 0.040 |
Why?
|
Sex Factors | 1 | 2012 | 10632 | 0.040 |
Why?
|
New York City | 1 | 2020 | 737 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2021 | 81762 | 0.040 |
Why?
|
DNA, Bacterial | 2 | 2016 | 1478 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 2 | 1990 | 3781 | 0.040 |
Why?
|
Brazil | 1 | 2022 | 1250 | 0.040 |
Why?
|
Disease Vectors | 1 | 2017 | 61 | 0.040 |
Why?
|
Risk | 2 | 2021 | 9613 | 0.040 |
Why?
|
Ecdysterone | 1 | 2016 | 13 | 0.030 |
Why?
|
Particle Size | 1 | 2021 | 1649 | 0.030 |
Why?
|
Bacterial Proteins | 1 | 2010 | 3840 | 0.030 |
Why?
|
Burkina Faso | 1 | 2016 | 88 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2022 | 830 | 0.030 |
Why?
|
Aotidae | 1 | 2016 | 57 | 0.030 |
Why?
|
Parasitic Sensitivity Tests | 1 | 2016 | 90 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 1 | 2016 | 611 | 0.030 |
Why?
|
Pregnant Women | 1 | 2020 | 576 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2021 | 718 | 0.030 |
Why?
|
Immunization Programs | 1 | 2018 | 267 | 0.030 |
Why?
|
Environment | 1 | 2021 | 1121 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.030 |
Why?
|
Immunization | 2 | 2017 | 1219 | 0.030 |
Why?
|
Benchmarking | 1 | 2021 | 1057 | 0.030 |
Why?
|
Serotyping | 1 | 2015 | 331 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 2018 | 560 | 0.030 |
Why?
|
Social Behavior | 1 | 2021 | 1147 | 0.030 |
Why?
|
Larva | 1 | 2016 | 515 | 0.030 |
Why?
|
Senegal | 1 | 2014 | 256 | 0.030 |
Why?
|
Vaccines, Conjugate | 1 | 2015 | 334 | 0.030 |
Why?
|
Symbiosis | 1 | 2016 | 297 | 0.030 |
Why?
|
Genome | 1 | 2021 | 1754 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2022 | 1397 | 0.030 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2014 | 134 | 0.030 |
Why?
|
Primates | 1 | 2016 | 520 | 0.030 |
Why?
|
World Health Organization | 1 | 2019 | 1329 | 0.030 |
Why?
|
Case Management | 1 | 2015 | 277 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 30256 | 0.030 |
Why?
|
Heterochromatin | 1 | 2014 | 294 | 0.020 |
Why?
|
Viral Load | 1 | 2021 | 3396 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1793 | 0.020 |
Why?
|
Databases, Factual | 2 | 2020 | 8080 | 0.020 |
Why?
|
Papua New Guinea | 1 | 2010 | 47 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2021 | 2008 | 0.020 |
Why?
|
Cyanogen Bromide | 1 | 1990 | 75 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12795 | 0.020 |
Why?
|
Health Planning | 1 | 2012 | 233 | 0.020 |
Why?
|
Multilocus Sequence Typing | 1 | 2010 | 102 | 0.020 |
Why?
|
Antibody Diversity | 1 | 1990 | 72 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5315 | 0.020 |
Why?
|
Linear Models | 1 | 2020 | 5884 | 0.020 |
Why?
|
Immunoblotting | 2 | 1990 | 1647 | 0.020 |
Why?
|
Phenotype | 3 | 2016 | 16726 | 0.020 |
Why?
|
Treatment Failure | 1 | 2016 | 2661 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2015 | 2923 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2012 | 806 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2013 | 1997 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2020 | 3205 | 0.020 |
Why?
|
Microsatellite Repeats | 1 | 2010 | 785 | 0.020 |
Why?
|
Meningococcal Infections | 1 | 2008 | 78 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2016 | 2131 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2012 | 7608 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8509 | 0.020 |
Why?
|
History, 21st Century | 1 | 2013 | 1573 | 0.020 |
Why?
|
Lactic Acid | 1 | 2012 | 1140 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12840 | 0.020 |
Why?
|
Emigrants and Immigrants | 1 | 2013 | 550 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6316 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 1990 | 3814 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2013 | 2363 | 0.020 |
Why?
|
Telomere | 1 | 2012 | 944 | 0.020 |
Why?
|
Prospective Studies | 2 | 2020 | 54926 | 0.020 |
Why?
|
Temperature | 1 | 2012 | 2234 | 0.020 |
Why?
|
History, 20th Century | 1 | 2013 | 2766 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2008 | 1162 | 0.010 |
Why?
|
Genes, Bacterial | 1 | 2008 | 1076 | 0.010 |
Why?
|
Cognition | 1 | 2021 | 7073 | 0.010 |
Why?
|
Genome, Bacterial | 1 | 2008 | 796 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15948 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3833 | 0.010 |
Why?
|
Autoantibodies | 1 | 1988 | 2121 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39348 | 0.010 |
Why?
|
Mutation | 1 | 2024 | 30238 | 0.010 |
Why?
|
Chromosomes | 1 | 2002 | 578 | 0.010 |
Why?
|
Multigene Family | 1 | 2002 | 1081 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19015 | 0.010 |
Why?
|
Rats, Inbred Strains | 2 | 1991 | 2087 | 0.010 |
Why?
|
Peptides | 1 | 1990 | 4354 | 0.010 |
Why?
|
Protein Binding | 1 | 1990 | 9343 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18349 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9538 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 65371 | 0.010 |
Why?
|
Proteome | 1 | 2002 | 1890 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14729 | 0.010 |
Why?
|
Protein Denaturation | 1 | 1991 | 242 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1988 | 1065 | 0.000 |
Why?
|
Antibody Formation | 1 | 1991 | 1393 | 0.000 |
Why?
|
Arthritis | 1 | 1991 | 684 | 0.000 |
Why?
|
Cattle | 1 | 1991 | 3819 | 0.000 |
Why?
|
Epitopes | 1 | 1991 | 2528 | 0.000 |
Why?
|
Rats | 2 | 1991 | 23760 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1991 | 5151 | 0.000 |
Why?
|
Concepts
(424)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(48)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_